These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 6979554)
1. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. Alcocer-Varela J; Alarcón-Segovia D J Clin Invest; 1982 Jun; 69(6):1388-92. PubMed ID: 6979554 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus. Alcocer-Varela J; Alarcón-Segovia D Rheumatol Int; 1995; 15(2):57-63. PubMed ID: 7481481 [TBL] [Abstract][Full Text] [Related]
4. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus. Sierakowski S; Kucharz EJ Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032 [TBL] [Abstract][Full Text] [Related]
5. Defects of autologous mixed lymphocyte reaction-activated immunoregulatory T cells in patients with systemic lupus erythematosus. Koide J; Takeuchi T; Hosono O; Takano M; Abe T Scand J Immunol; 1987 Oct; 26(4):363-9. PubMed ID: 2961048 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity. Wigfall DR; Sakai RS; Wallace DJ; Jordan SC Clin Immunol Immunopathol; 1988 Jun; 47(3):354-62. PubMed ID: 3131053 [TBL] [Abstract][Full Text] [Related]
7. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus]. Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of T cell mediated regulation of anti-DNA production in systemic lupus erythematosus. Clough JD; Frank SA; Calabrese LH Arthritis Rheum; 1980 Jan; 23(1):24-9. PubMed ID: 6965452 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Miyasaka N; Nakamura T; Russell IJ; Talal N Clin Immunol Immunopathol; 1984 Apr; 31(1):109-17. PubMed ID: 6421522 [TBL] [Abstract][Full Text] [Related]
10. Abnormal production of and response to B-cell growth factor and B-cell differentiation factor in patients with systemic lupus erythematosus. Hirose T; Hara M; Kitani A; Hirose W; Norioka K; Kawagoe M; Nakamura H Scand J Immunol; 1985 Feb; 21(2):141-50. PubMed ID: 3871963 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 2 receptors and responsiveness to recombinant human interleukin 2 in patients with systemic lupus erythematosus. Lakhanpal S; Handwerger BS Mayo Clin Proc; 1987 Jan; 62(1):3-7. PubMed ID: 3099102 [TBL] [Abstract][Full Text] [Related]
12. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275 [TBL] [Abstract][Full Text] [Related]
13. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus. Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941 [TBL] [Abstract][Full Text] [Related]
14. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus. Funauchi M; Sugishima H; Minoda M; Horiuchi A J Rheumatol; 1991 Mar; 18(3):368-72. PubMed ID: 1906936 [TBL] [Abstract][Full Text] [Related]
15. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides. Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240 [TBL] [Abstract][Full Text] [Related]
16. T lymphocytes from patients with systemic lupus erythematosus show increased response to interleukin-2 after costimulation with OKT3 monoclonal antibody and phorbol esters. Blasini AM; Stekman IL; Gonzalez F; Tositti ML; Rodriguez MA Clin Immunol Immunopathol; 1994 Jan; 70(1):66-72. PubMed ID: 8261671 [TBL] [Abstract][Full Text] [Related]
17. Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. Linker-Israeli M; Bakke AC; Quismorio FP; Horwitz DA J Clin Invest; 1985 Feb; 75(2):762-8. PubMed ID: 3156152 [TBL] [Abstract][Full Text] [Related]
18. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490 [TBL] [Abstract][Full Text] [Related]
19. Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production. Karampetsou MP; Comte D; Kis-Toth K; Terhorst C; Kyttaris VC; Tsokos GC J Immunol; 2016 Jun; 196(12):4915-24. PubMed ID: 27183584 [TBL] [Abstract][Full Text] [Related]
20. T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2. Draeger AM; Swaak AJ; van den Brink HG; Aarden LA Clin Exp Immunol; 1986 Apr; 64(1):80-7. PubMed ID: 3488149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]